EU regulator reviews Pfizer-BioNTech COVID shot in children as young as 6 months | Reuters
The European Medicines Agency on Monday started reviewing a low-dose version of BioNTech and Pfizer’s COVID-19 vaccine for use in children between the age of six months and four years.